502 related articles for article (PubMed ID: 29599502)
21. Antibodies to antigenic site A of influenza H7 hemagglutinin provide protection against H7N9 challenge.
Schmeisser F; Vasudevan A; Verma S; Wang W; Alvarado E; Weiss C; Atukorale V; Meseda C; Weir JP
PLoS One; 2015; 10(1):e0117108. PubMed ID: 25629172
[TBL] [Abstract][Full Text] [Related]
22. H7N9: can H7N3 live-attenuated influenza vaccine be used at the early stage of the pandemic?
Rudenko L; Isakova-Sivak I; Rekstin A
Expert Rev Vaccines; 2014 Jan; 13(1):1-4. PubMed ID: 24308582
[TBL] [Abstract][Full Text] [Related]
23. Characterization of Humoral Responses Induced by an H7N9 Influenza Virus-Like Particle Vaccine in BALB/C Mice.
Zhang L; Lu J; Chen Y; Shi F; Yu H; Huang C; Cui L; Shi Z; Jiao Y; Hu Y
Viruses; 2015 Aug; 7(8):4369-84. PubMed ID: 26248076
[TBL] [Abstract][Full Text] [Related]
24. Modified vaccinia virus Ankara expressing the hemagglutinin of pandemic (H1N1) 2009 virus induces cross-protective immunity against Eurasian 'avian-like' H1N1 swine viruses in mice.
Castrucci MR; Facchini M; Di Mario G; Garulli B; Sciaraffia E; Meola M; Fabiani C; De Marco MA; Cordioli P; Siccardi A; Kawaoka Y; Donatelli I
Influenza Other Respir Viruses; 2014 May; 8(3):367-75. PubMed ID: 24373385
[TBL] [Abstract][Full Text] [Related]
25. A single cycle influenza virus coated in H7 haemagglutinin generates neutralizing antibody responses to haemagglutinin and neuraminidase glycoproteins and protection from heterotypic challenge.
Powell TJ; Rijal P; McEwen-Smith RM; Byun H; Hardwick M; Schimanski LM; Huang KA; Daniels RS; Townsend ARM
J Gen Virol; 2019 Mar; 100(3):431-445. PubMed ID: 30714896
[TBL] [Abstract][Full Text] [Related]
26. Production and characterization of mammalian virus-like particles from modified vaccinia virus Ankara vectors expressing influenza H5N1 hemagglutinin and neuraminidase.
Schmeisser F; Adamo JE; Blumberg B; Friedman R; Muller J; Soto J; Weir JP
Vaccine; 2012 May; 30(23):3413-22. PubMed ID: 22465746
[TBL] [Abstract][Full Text] [Related]
27. A viable recombinant rhabdovirus lacking its glycoprotein gene and expressing influenza virus hemagglutinin and neuraminidase is a potent influenza vaccine.
Ryder AB; Buonocore L; Vogel L; Nachbagauer R; Krammer F; Rose JK
J Virol; 2015 Mar; 89(5):2820-30. PubMed ID: 25540378
[TBL] [Abstract][Full Text] [Related]
28. A Bivalent Heterologous DNA Virus-Like-Particle Prime-Boost Vaccine Elicits Broad Protection against both Group 1 and 2 Influenza A Viruses.
Jiang W; Wang S; Chen H; Ren H; Huang X; Wang G; Chen Z; Chen L; Chen Z; Zhou P
J Virol; 2017 May; 91(9):. PubMed ID: 28179535
[TBL] [Abstract][Full Text] [Related]
29. Efficacy of novel recombinant fowlpox vaccine against recent Mexican H7N3 highly pathogenic avian influenza virus.
Criado MF; Bertran K; Lee DH; Killmaster L; Stephens CB; Spackman E; Sa E Silva M; Atkins E; Mebatsion T; Widener J; Pritchard N; King H; Swayne DE
Vaccine; 2019 Apr; 37(16):2232-2243. PubMed ID: 30885512
[TBL] [Abstract][Full Text] [Related]
30. Virus-like particles displaying H5, H7, H9 hemagglutinins and N1 neuraminidase elicit protective immunity to heterologous avian influenza viruses in chickens.
Pushko P; Tretyakova I; Hidajat R; Zsak A; Chrzastek K; Tumpey TM; Kapczynski DR
Virology; 2017 Jan; 501():176-182. PubMed ID: 27936463
[TBL] [Abstract][Full Text] [Related]
31. Protective immunity against influenza in HLA-A2 transgenic mice by modified vaccinia virus Ankara vectored vaccines containing internal influenza proteins.
Di Mario G; Sciaraffia E; Facchini M; Gubinelli F; Soprana E; Panigada M; Bernasconi V; Garulli B; Siccardi A; Donatelli I; Castrucci MR
Pathog Glob Health; 2017 Mar; 111(2):76-82. PubMed ID: 28079473
[TBL] [Abstract][Full Text] [Related]
32. Cross-Reactive Neuraminidase-Inhibiting Antibodies Elicited by Immunization with Recombinant Neuraminidase Proteins of H5N1 and Pandemic H1N1 Influenza A Viruses.
Liu WC; Lin CY; Tsou YT; Jan JT; Wu SC
J Virol; 2015 Jul; 89(14):7224-34. PubMed ID: 25948745
[TBL] [Abstract][Full Text] [Related]
33. Immunobiological properties of influenza A (H7N9) hemagglutinin and neuraminidase proteins.
Jiang L; Changsom D; Lerdsamran H; Wiriyarat W; Masamae W; Noisumdaeng P; Jongkaewwattana A; Puthavathana P
Arch Virol; 2016 Oct; 161(10):2693-704. PubMed ID: 27406044
[TBL] [Abstract][Full Text] [Related]
34. Recombinant influenza H7 hemagglutinin containing CFLLC minidomain in the transmembrane domain showed enhanced cross-protection in mice.
Wang Y; Zhang Y; Wu J; Lin Y; Wu Z; Wei Y; Wei X; Qin J; Xue C; Liu GD; Cao Y
Virus Res; 2017 Oct; 242():16-23. PubMed ID: 28912070
[TBL] [Abstract][Full Text] [Related]
35. Optimal designs of an HA-based DNA vaccine against H7 subtype influenza viruses.
Zhang L; Jia N; Li J; Han Y; Cao W; Wang S; Huang Z; Lu S
Hum Vaccin Immunother; 2014; 10(7):1949-58. PubMed ID: 25424804
[TBL] [Abstract][Full Text] [Related]
36. Plant-derived H7 VLP vaccine elicits protective immune response against H7N9 influenza virus in mice and ferrets.
Pillet S; Racine T; Nfon C; Di Lenardo TZ; Babiuk S; Ward BJ; Kobinger GP; Landry N
Vaccine; 2015 Nov; 33(46):6282-9. PubMed ID: 26432915
[TBL] [Abstract][Full Text] [Related]
37. Intramuscular and intranasal immunization with an H7N9 influenza virus-like particle vaccine protects mice against lethal influenza virus challenge.
Ren Z; Zhao Y; Liu J; Ji X; Meng L; Wang T; Sun W; Zhang K; Sang X; Yu Z; Li Y; Feng N; Wang H; Yang S; Yang Z; Ma Y; Gao Y; Xia X
Int Immunopharmacol; 2018 May; 58():109-116. PubMed ID: 29571081
[TBL] [Abstract][Full Text] [Related]
38. A single immunization with modified vaccinia virus Ankara-based influenza virus H7 vaccine affords protection in the influenza A(H7N9) pneumonia ferret model.
Kreijtz JH; Wiersma LC; De Gruyter HL; Vogelzang-van Trierum SE; van Amerongen G; Stittelaar KJ; Fouchier RA; Osterhaus AD; Sutter G; Rimmelzwaan GF
J Infect Dis; 2015 Mar; 211(5):791-800. PubMed ID: 25246535
[TBL] [Abstract][Full Text] [Related]
39. L226Q Mutation on Influenza H7N9 Virus Hemagglutinin Increases Receptor-Binding Avidity and Leads to Biased Antigenicity Evaluation.
Wang Y; Lv Y; Niu X; Dong J; Feng P; Li Q; Xu W; Li J; Li C; Li J; Luo J; Li Z; Liu Y; Tan YJ; Pan W; Chen L
J Virol; 2020 Sep; 94(20):. PubMed ID: 32796071
[TBL] [Abstract][Full Text] [Related]
40. Recombinant virus-like particles elicit protective immunity against avian influenza A(H7N9) virus infection in ferrets.
Liu YV; Massare MJ; Pearce MB; Sun X; Belser JA; Maines TR; Creager HM; Glenn GM; Pushko P; Smith GE; Tumpey TM
Vaccine; 2015 Apr; 33(18):2152-8. PubMed ID: 25772674
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
